Réaction #79744

Équation de réaction

tri-n-butyltin hydride

4-methoxy-6-methoxycarbonyl-10-phenylmethyl-6,7,8,9,9a,10-hexahydropyrido[1,2-a]indole

methyl 2-[3-phenylmethyl-7-methoxyindol-1-yl]pentanoate

2,2′-azobis(2-methylpropionitrile)

→

title compound

4-methoxy-6-methoxycarbonyl-10-phenylmethyl-6,7,8,9-tetrahydropyrido[1,2-a]indole

Solvants

dioxane

toluene

Conditions de réaction

Traitement

1. 1
   Températureto reflux
2. 2
   TempératureThe solution was refluxed 1 hour
3. 3
   workup.ADDITIONafter the addition
4. 4
   Températurecooled
5. 5
   Autreevaporated in vacuo
6. 6
   Filtrationfiltered
7. 7
   LavageThe organic phase was washed with saturated sodium chloride
8. 8
   Séchagedried over sodium sulfate
9. 9
   Autreevaporated in vacuo
10. 10
    Autreto give
11. 11
    AutreThe solution was evaporated in vacuo
12. 12
    Filtrationfiltered through florisil
13. 13
    Autreevaporated in vacuo
14. 14
    AutreThe residue was chromatographed on silica gel eluting with a gradient hexane/10-20% ethyl ether

Mode opératoire

A solution of 1.8 gm (4.7 mmol) of the product from Part B and 4 mL (15 mmol) of tri-n-butyltin hydride in 50 mL of toluene was heated to reflux and treated dropwise with a solution of 85 mg (0.5 mmol) of 2,2′-azobis(2-methylpropionitrile). The solution was refluxed 1 hour after the addition, cooled, evaporated in vacuo, taken up in ethyl acetate, shaken with aqueous potassium floride, and filtered. The organic phase was washed with saturated sodium chloride, dried over sodium sulfate, and evaporated in vacuo to give a mixture of 4-methoxy-6-methoxycarbonyl-10-phenylmethyl-6,7,8,9,9a,10-hexahydropyrido[1,2-a]indole and methyl 2-[3-phenylmethyl-7-methoxyindol-1-yl]pentanoate which was dissolved in 25 mL of dioxane and stirred with 450 mg (2 mmol) of dichlorodicyanoquinone for 30 minutes. The solution was evaporated in vacuo, taken up in dichloromethane, filtered through florisil, and evaporated in vacuo. The residue was chromatographed on silica gel eluting with a gradient hexane/10-20% ethyl ether to give the title compound, 75 mg, 5%, as an amorphous solid. 1H NMR (CDCl3) δ: 1.70 (m, 1H), 1.85 (m, 1H), 2.20 (m, 1H), 2.35 (m, 1H), 2.70 (m, 1H), 3.00 (m, 1H), 3.70 (s, 3H), 3.80 (s, 3H), 4.00 (q, 2H), 5.65 (m, 1H), 6.50 (d, 1H), 6.90 (t, 1H), 7.00 (d, 1H), 7.10 (m, 1H), 7.20 (m, 4H).

Source